Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong.
Clin J Am Soc Nephrol. 2011 Apr;6(4):805-12. doi: 10.2215/CJN.07130810. Epub 2011 Jan 6.
Heart failure occurs frequently in end-stage renal disease patients. However, there are no prospective, longitudinal follow-up data on its prevalence, severity, and risk factors in long-term peritoneal dialysis (PD) patients.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A prospective observational study was conducted in 220 long-term PD patients followed up for 4 years or until death. Echocardiography was obtained at baseline. Primary study end points were heart failure and mortality.
Eighty-six patients had a previous history of heart failure at study entry. The cumulative 4-year survival probability was 37.4% and 64.7% for patients with and without previous heart failure, respectively (P<0.0001). During follow-up, 87 patients (40.9%) developed heart failure, of which 53 were recurrence and 34 were new-onset heart failure. Diabetes, background atherosclerotic vascular disease, systolic hypertension, left ventricular (LV) mass index, systolic dysfunction, and hypoalbuminemia were significant risk factors predicting heart failure in the entire cohort. Diabetes and LV mass and volume index were significant predictors of new-onset heart failure. Systolic hypertension, LV volume index, and hypoalbuminemia were significant predictors of recurrent heart failure.
Heart failure is a highly prevalent complication in long-term PD patients and predicts adverse clinical outcomes. More attention should be focused on improving BP and volume control and identifying treatment strategies that effectively lower atherosclerotic burden and reverse LV hypertrophy, remodeling, and systolic dysfunction in PD patients.
心力衰竭在终末期肾病患者中较为常见。然而,目前尚缺乏长期腹膜透析(PD)患者中该病的患病率、严重程度及其危险因素的前瞻性、纵向随访数据。
设计、设置、参与者和测量方法:对 220 例长期 PD 患者进行了前瞻性观察性研究,随访 4 年或直至死亡。在基线时获取了超声心动图。主要研究终点为心力衰竭和死亡率。
86 例患者在研究入组时即有心力衰竭既往史。有和无既往心力衰竭的患者的 4 年累积生存率分别为 37.4%和 64.7%(P<0.0001)。随访期间,87 例患者(40.9%)发生了心力衰竭,其中 53 例为心力衰竭复发,34 例为新发心力衰竭。糖尿病、背景动脉粥样硬化性血管疾病、收缩期高血压、左心室(LV)质量指数、收缩功能障碍和低白蛋白血症是整个队列中预测心力衰竭的显著危险因素。糖尿病和 LV 质量和容积指数是新发心力衰竭的显著预测因素。收缩期高血压、LV 容积指数和低白蛋白血症是心力衰竭复发的显著预测因素。
心力衰竭是长期 PD 患者中一种高发并发症,可预测不良临床结局。应更加关注改善血压和容量控制,并确定能有效降低 PD 患者动脉粥样硬化负担并逆转 LV 肥厚、重塑和收缩功能障碍的治疗策略。